Invesco NASDAQ Biotech UCITS ETF Acc - USD Stock price

ETF

SBIO

IE00BQ70R696

Delayed London S.E. 12:35:12 2024-03-28 pm EDT 5-day change 1st Jan Change
46 USD +0.36% Intraday chart for Invesco NASDAQ Biotech UCITS ETF Acc - USD +2.62% +0.94%
Dynamic Chart

Investment objective

The Invesco NASDAQ Biotech UCITS ETF Acc aims to provide the performance of the NASDAQ Biotechnology Index, after fees. The index comprises biotechnology and pharmaceuticals companies (as defined by ICB) listed on the NASDAQ Stock Market. Stocks are filtered to meet minimum market capitalisation and liquidity requirements. They are then weighted by modified market capitalisation: the largest five constituents are capped at 8%; the remaining constituents are capped at 4%. The index is rebalanced quarterly and reviewed annually in December.
In partnership with
TrackInsight
Date Price Change Volume
24-03-28 46 +0.36% 37,298
24-03-27 45.84 +1.04% 18,969
24-03-26 45.37 +0.27% 14,422
24-03-25 45.25 -0.18% 72,257
24-03-22 45.33 -1.04% 8,473

Delayed Quote London S.E.

Last update March 28, 2024 at 12:35 pm EDT

More quotes

ETF Ratings

Description

IE00BQ70R696
Total Expense Ratio 0.40%
Asset Class
Sector
Size
Currency
Provider
Underlying NASDAQ Biotechnology Total Return Index - USD

Features and characteristics

Jurisdiction
Replication Method
Replication Model
Date of creation
2014-11-06
Dividend Policy
Geographical Focus

Distribution

Retail investor

AuM evolution ( 2024-02-28 )

AuM (EUR) 599 M€
AuM 1M 560 M€
AuM 3 months 463 M€
AuM 6 months 540 M€
AuM 12 months 564 M€
  1. Stock
  2. ETF
  3. ETF Invesco NASDAQ Biotech UCITS ETF Acc - USD - London S.E.